Боль при боковом амиотрофическом склерозе

Автор: Войтенков Владислав Борисович, Екушева Евгения Викторовна

Журнал: Клиническая практика @clinpractice

Статья в выпуске: 2 т.10, 2019 года.

Бесплатный доступ

В обзоре рассматриваются различные аспекты болевого синдрома у пациентов с боковым амиотрофическим синдромом: этиология, распространенность, основные клинические характеристики и патофизиологические особенности. Представлены современные аспекты ведения этой категории больных. У пациентов с боковым амиотрофическим склерозом болевой синдром не является редкостью и сопровождает до 80% случаев, осложняя течение и без того неуклонно прогрессирующего заболевания. Боль при боковом амиотрофическом склерозе достоверно снижает функциональную активность и качество жизни пациентов, повышает частоту развития аффективных расстройств. Болевой синдром часто остается вне поля зрения клиницистов, сосредоточенных главным образом на наличии и прогрессировании «моторного» дефицита. Все вышеизложенное диктует необходимость более внимательного подхода к диагностике и лечению болевого синдрома у пациентов с боковым амиотрофическим склерозом.

Еще

Боковой амиотрофический склероз, болевой синдром, невропатическая боль, центральная сенситизация

Короткий адрес: https://sciup.org/143168169

IDR: 143168169 | DOI: 10.17816/clinpract10266-73

Список литературы Боль при боковом амиотрофическом склерозе

Живолупов С.А., Рашидов Н.А., Самарцев И.Н., Галицкий С.А. Боковой амиотрофический склероз (современные представления, прогнозирование исходов, эволюция медицинской стратегии)//Вестник Российской военно-медицинской академии. -2011. -№3. -С. 244-251.
Захарова М.Н., Иллариошкин С.Н., Лысогорская Е.В., и др. Боковой амиотрофический склероз. В кн.: Неврология. Национальное руководство. Краткое издание./Под ред. Е.И. Гусева, А.Н. Коновалова, А.Б. Гехт. -М.: ГЭОТАР-Медиа; 2014. -688 с.
Wicks P. Reassessing received wisdom in ALS -pain is common when studied systematically. Eur J Neurol. 2012;19(4):531-532 DOI: 10.1111/j.1468-1331.2011.03541.x
Nicholson K, Murphy A, McDonnell E, et al. Improving symptom management for people with amyotrophic lateral sclerosis. Muscle Nerve. 2018;57(1):20-24 DOI: 10.1002/mus.25712
Delpont B, Beauvais K, Jacquin-Piques A, et al. Clinical features of pain in amyotrophic lateral sclerosis: a clinical challenge. Rev Neurol (Paris). 2019;175 (1-2):11-15 DOI: 10.1016/j.neurol.2017.11.009
Handy CR, Krudy C, Boulis N, Federici T. Pain in amyotrophic lateral sclerosis: a neglected aspect of disease. Neurol Res Int. 2011;2011:403808
DOI: 10.1155/2011/403808
Екушева Е.В. Сенсомоторная интеграция при поражении центральной нервной системы: клинические и патогенетические аспекты: Автореф. дис.... докт. мед. наук. -М.; 2016. -48 с. Доступно по: https://search.rsl.ru/ru/record/01006661768. Ссылка активна на 14.02.2019.
Chiò A, Canosa A, Gallo S, et al. Pain in amyotrophic lateral sclerosis: a population-based controlled study. Eur J Neurol. 2012;19(4):551-555
DOI: 10.1111/j.1468-1331.2011.03540.x
Raheja D, Stephens HE, Lehman E, et al. Patient-reported problematic symptoms in an ALS treatment trial. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17(3-4):198-205
DOI: 10.3109/21678421.2015.1131831
Wallace VC, Ellis CM, Burman R, et al. The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(7-8):520-527
DOI: 10.3109/21678421.2014.951944
Nolano M, Provitera V, Manganelli F, et al. Non-motor involvement in amyotrophic lateral sclerosis: new insight from nerve and vessel analysis in skin biopsy. Neuropathol Appl Neurobiol. 2017;43(2):119-132
DOI: 10.1111/nan.12332
Vucic S. Sensory and autonomic nervous system dysfunction in amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 2017;43(2):99-101
DOI: 10.1111/nan.12336
Hanisch F, Skudlarek A, Berndt J, Kornhuber ME. Characteristics of pain in amyotrophic lateral sclerosis. Brain Behav. 2015;5(3):e00296
DOI: 10.1002/brb3.296
de Castro-Costa CM, Oria RB, Machado-Filho JA, et al. Amyotrophic lateral sclerosis. Clinical analysis of 78 cases from Fortaleza (northeastern Brazil). Arq Neuropsiquiatr. 1999;57(3B):761-774
DOI: 10.1590/s0004-282x1999000500006
Truini A, Biasiotta A, Onesti E, et al. Small-fibre neuropathy related to bulbar and spinal-onset in patients with ALS. J Neurol. 2015;262(4):1014-1018
DOI: 10.1007/s00415-015-7672-0
Dalla Bella E, Lombardi R, Porretta-Serapiglia C, et al. Amyotrophic lateral sclerosis causes small fiber pathology. Eur J Neurol. 2016;23(2):416-420
DOI: 10.1111/ene.12936
Chiò A, Mora G, Lauria G. Pain in amyotrophic lateral sclerosis. Lancet Neurol. 2017;16(2):144-157
DOI: 10.1016/S1474-4422(16)30358-1
Stephens HE, Lehman E, Raheja D, et al. Pain in amyotrophic lateral sclerosis: patient and physician perspectives and practices. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1-2):21-29
DOI: 10.3109/21678421.2015.1074701
Pizzimenti A, Aragona M, Onesti E, Inghilleri M. Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study. Funct Neurol. 2013;28(2):115-119
DOI: 10.11138/FNeur/2013.28.2.115
Jensen MP, Abresch RT, Carter GT, McDonald CM. Chronic pain in persons with neuromuscular disease. Arch Phys Med Rehabil. 2005;86(6):1155-1163
DOI: 10.1016/j.apmr.2004.11.028
Abe Y, Miyashita M, Ito N, et al. Attitude of outpatients with neuromuscular diseases in Japan to pain and use of analgesics. J Neurol Sci. 2008;267(1-2):22-27
DOI: 10.1016/j.jns.2007.09.027
Lopes LC, Galhardoni R, Silva V, et al. Beyond weakness: characterization of pain, sensory profile and conditioned pain modulation in patients with motor neuron disease: a controlled study. Eur J Pain. 2018;22(1):72-83
DOI: 10.1002/ejp.1091
Moisset X, Cornut-Chauvinc C, Clavelou P, et al. Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study. Palliat Med. 2016;30(5):486-494
DOI: 10.1177/0269216315600332
Miller TM, Layzer RB. Muscle cramps. Muscle Nerve. 2005;32(4):431-442
DOI: 10.1002/mus.20341
Caress JB, Ciarlone SL, Sullivan EA, et al. Natural history of muscle cramps in amyotrophic lateral sclerosis. Muscle Nerve. 2016;53(4):513-517
DOI: 10.1002/mus.24892
de Carvalho M, Swash M. Cramps, muscle pain, and fasciculations: not always benign? Neurology. 2004;63(4):721-723
DOI: 10.1212/01.wnl.0000134609.56166.15
D’Ovidio F, d’Errico A, Farina E, et al. Amyotrophic lateral sclerosis incidence and previous prescriptions of drugs for the nervous system. Neuroepidemiology. 2016;47(1):59-66
DOI: 10.1159/000448618
Ho DT, Ruthazer R, Russell JA. Shoulder pain in amyotrophic lateral sclerosis. J Clin Neuromuscul Dis. 2011;13(1):53-55
DOI: 10.1097/CND.0b013e31821c5623
Burke K, Ellrodt AS, Levine J, et al. Exploring the use of educational material about shoulder dysfunction: a quality improvement project in people with amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2018;97(5):379-382
DOI: 10.1097/PHM.0000000000000885
Goy ER, Carter J, Ganzini L. Neurologic disease at the end of life: caregiver descriptions of Parkinson disease and amyotrophic lateral sclerosis. J Palliat Med. 2008;11(4):548-554
DOI: 10.1089/jpm.2007.0258
Hirano YM, Yamazaki Y, Shimizu J, et al. Ventilator dependence and expressions of need: a study of patients with amyotrophic lateral sclerosis in Japan. Soc Sci Med. 2006;62(6):1403-1413
DOI: 10.1016/j.socscimed.2005.08.015
Попова Л.М. Амиотрофический боковой склероз в условиях продленной жизни. -М.: Медицина; 1998. -143 с.
Rivera I, Ajroud-Driss S, Casey P, et al. Prevalence and characteristics of pain in early and late stages of ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(5-6):369-372
DOI: 10.3109/21678421.2012.751614
Ganzini L, Johnston WS, Hoffman WF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology. 1999;52(7):1434-1440
DOI: 10.1212/wnl.52.7.1434
Adelman EE, Albert SM, Rabkin JG, et al. Disparities in perceptions of distress and burden in ALS patients and family caregivers. Neurology. 2004;62(10):1766-1770
DOI: 10.1212/01.wnl.0000125180.04000.a4
Weis J, Katona I, Muller-Newen G, et al. Small-fiber neuropathy in patients with ALS. Neurology. 2011;76(23):2024-2029
DOI: 10.1212/WNL.0b013e31821e553a
Isak B, Pugdahl K, Karlsson P. Quantitative sensory testing and structural assessment of sensory nerve fibres in amyotrophic lateral sclerosis. J Neurol Sci. 2017;373:329-334
DOI: 10.1016/j.jns.2017.01.005
Brettschneider J, Kurent J, Ludolph A. Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev. 2013;5
DOI: 10.1002/14651858.cd005226.pub3
Atassi N, Cook A, Pineda C.M, et al. Depression in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12(2):109-112
DOI: 10.3109/17482968.2010.536839
Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83(1):102-108
DOI: 10.1136/jnnp-2011-300188
Stephens HE, Lehman E, Raheja D, et al. The role of mental health and selfefficacy in the pain experience of patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17 (3-4):206-212
DOI: 10.3109/21678421.2015.1131832
Ng L, Khan F, Young CA, Galea M. Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev. 2017;1:CD011776
DOI: 10.1002/14651858.CD011776.pub2
Weber M, Goldman B, Truniger S. Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial. J Neurol Neurosurg Psychiatry. 2010;81(10):1135-1140
DOI: 10.1136/jnnp.2009.200642
Giacoppo S, Mazzon E. Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis? Neural Regen Res. 2016;11(12):1896-1899
DOI: 10.4103/1673-5374.197125
Karst M. Schmerz. 2018;32(5):381-396
DOI: 10.1007/s00482-018-0299-1
Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol. 2010;17(9):1113-e88
DOI: 10.1111/j.1468-1331.2010.02999.x
El-Tawil S, Al Musa T, Valli H, et al. Quinine for muscle cramps. Cochrane Database Syst Rev. 2010;(12):CD005044
DOI: 10.1002/14651858.CD005044.pub2
Weiss MD, Macklin EA, Simmons Z, et al. A randomized trial of mexiletine in ALS: safety and effects on muscle cramps and progression. Neurology. 2016;86(16):1474-1481
DOI: 10.1212/WNL.0000000000002507
Bedlack RS, Pastula DM, Hawes J, Heydt D. Open-label pilot trial of levetiracetam for cramps and spasticity in patients with motor neuron disease. Amyotroph Lateral Scler. 2009;10(4):210-215
DOI: 10.1080/17482960802430773
Newrick PG, Langton-Hewer R. Pain in motor neuron disease. J Neurol Neurosurg Psychiatry. 1985;48(8):838-840
DOI: 10.1136/jnnp.48.8.838
O’Brien T, Kelly M, Saunders C. Motor neurone di-sease: a hospice perspective. BMJ. 1992;304(6825):471-473
DOI: 10.1136/bmj.304.6825.471
Bello-Haas VD. Physical therapy for individuals with amyotrophic lateral sclerosis: current insights. Degener Neurol Neuromuscul Dis. 2018;8:45-54
DOI: 10.2147/DNND.S146949
Екушева Е.В., Данилов А.Б. Наследственная спастическая параплегия//Журнал неврологии и психиатрии им. С.С. Корсакова. -2002. -Т.102. -№8. -С. 44-52.
Majmudar S, Wu J, Paganoni S. Rehabilitation in amyotrophic lateral sclerosis: why it matters. Muscle Nerve. 2014;50(1):4-13
DOI: 10.1002/mus.24202
Maggiani A, Tremolizzo L, Della Valentina A, et al. Osteopathic manual treatment for amyotrophic lateral sclerosis: a feasibility pilot study. Open Neurol J. 2016;10:59-66
DOI: 10.2174/1874205X01610010059
Sandstedt P, Littorin S, Johansson S, et al. Disability and contextual factors in patients with amyotrophic lateral sclerosis -a three-year observational study. J Neuromuscul Dis. 2018;5(4):439-449
DOI: 10.3233/JND-180322
Green S, Buchbinder R, Hetrick S. Physiotherapy interventions for shoulder pain. Cochrane Database Syst Rev. 2003;(2):CD004258
DOI: 10.1002/14651858.CD004258
Green S, Buchbinder R, Hetrick S. Acupuncture for shoulder pain. Cochrane Database Syst Rev. 2005;(2):CD005319
DOI: 10.1002/14651858.CD005319
Di Lazzaro V, Pellegrino G, Ranieri F, et al. Effects of repetitive TMS of the motor cortex on disease progression and on glutamate and GABA levels in ALS: A proof of principle study. Brain Stimul. 2017;10(5):1003-1005
DOI: 10.1016/j.brs.2017.05.003
Ni Z, Chen R. Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases. Transl Neurodegener. 2015;4:22
DOI: 10.1186/s40035-015-0045-x

Еще

Статья научная